News | January 18, 2012

Medtronic Endurant II Stent Graft Gains European Approval

January 18, 2011 – Medtronic Inc. announced the CE mark and international launch of the Endurant II AAA stent graft system, which can treat patients with abdominal aortic aneurysms through endovascular aortic repair (EVAR).

An abdominal aortic aneurysm (AAA) is a weakening or bulge in the segment of the aorta, the body’s main artery, which crosses through the abdomen. AAA is often called a “silent killer” because it rarely causes apparent symptoms until rupturing, which usually results in the patient’s death.

Developed in collaboration with more than 250 physicians from around the world and now available in most European countries, the new system encompasses the Endurant stent graft platform while adding new design features that enhance the device’s ease of use.

·         Beginning at the point of access, the new lower-profile delivery system –– with 35 percent extended hydrophilic coating for enhanced access to challenging anatomies –– allows the 28 mm-diameter bifurcated segment (the most commonly used size) to fit inside an 18 French outer diameter catheter (down from 20 French with the original device).

·         Second, the addition of two new contralateral limb lengths (156 and 199 mm) enables more configuration options requiring fewer total pieces.

·         Finally, the radiopacity of the distal end of the bifurcated segment’s contralateral gate has been improved to enhance visibility and aid with limb insertion, placement and deployment.  

In countries where the Endurant II stent graft is approved with the CE mark, the device is indicated for the endovascular treatment of abdominal aortic aneurysms in patients with a proximal neck ? 10 mm in length with ? 60° infrarenal and ? 45° suprarenal angulation and in patients with a proximal aortic neck ? 15 mm in length with ? 75° infrarenal and ? 60° suprarenal angulation.

In the United States, the Endurant II AAA stent graft system is expected to receive approval from the U.S. Food and Drug Administration (FDA) in 2012.

The original Endurant AAA stent graft system received FDA approval in December 2010.

For more information:


Related Content

FDA Grants Breakthrough Device Designation for Valiant Thoracoabdominal Aortic Aneurysm Stent Graft
News | Stent Grafts | October 09, 2019
Medtronic plc announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA...
PQ Bypass Granted IDE Approval to Start TORUS SFA Stent Graft Pivotal Study
News | Stent Grafts | October 08, 2019
PQ Bypass Inc. announced it has received full approval of its investigational device exemption (IDE) trial of the...
First U.S. Patient Receives Gore Tag Conformable Thoracic Stent Graft With Active Control
News | Stent Grafts | July 10, 2019
W. L. Gore & Associates Inc. (Gore) announced the first U.S. implant of the Gore Tag Conformable Thoracic Stent...
Gore Receives FDA Approval for Gore Tag Conformable Thoracic Stent Graft
Technology | Stent Grafts | May 15, 2019
W. L. Gore & Associates Inc. (Gore) announced the U.S. Food and Drug Administration (FDA) has granted regulatory...
Aortic Stent Graft Global Market to Reach $5.4 Billion by 2028
News | Stent Grafts | February 14, 2019
Abdominal aortic stent grafts will remain the largest segment in the global aortic stent graft market at least through...
Medtronic Receives FDA Approval for Valiant Navion Thoracic Stent Graft System
Technology | Stent Grafts | February 07, 2019
Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for the Valiant Navion thoracic stent...
Endologix Ends Unrestricted Sales and Use of Nellix System
News | Stent Grafts | January 07, 2019
January 7, 2019 — Endologix Inc.
Endologix Reports Positive One-Year Results From the Ovation LUCY Study
News | Stent Grafts | July 16, 2018
Endologix Inc. announced one-year results from the LUCY (Evaluation of FemaLes who are Underrepresented Candidates for...
FDA Committee Votes in Favor of Incraft AAA Stent Graft System
News | Stent Grafts | June 13, 2018
Cardinal Health announced that its Incraft Abdominal Aortic Aneurysm (AAA) Stent Graft System has received a favorable...
First Patient Enrolled in Gore Excluder Investigational Study
News | Stent Grafts | January 08, 2018
January 8, 2018 — W. L. Gore & Associates Inc.